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COMMENTARY Open Access
Development of the Good Health
Research Practice course: ensuring
quality across all health research in
humans
Patricia Henley1, Varalakshmi Elango2, Olaf Horstick3, Riris Andono Ahmad4, Christine Maure5, Pascal Launois6,
Corinne Merle1,6, Jamila Nabieva7 and Yodi Mahendradhata4*
Abstract
Quality and ethics need to be embedded into all areas of research with human participants. Good Clinical
Practice (GCP) guidelines are international ethical and scientific quality standards for designing, conducting,
recording and reporting trials involving human participants. Compliance with GCP is expected to provide
public assurance that the rights, safety and wellbeing of participants are protected and that the clinical
research data are credible. However, whilst GCP guidelines, particularly their principles, are recommended
across all research types, it is difficult for non-clinical trial research to fit in with the exacting requirements of
GCP. There is therefore a need for guidance that allows health researchers to adhere to the principles of GCP,
which will improve the quality and ethical conduct of all research involving human participants. These
concerns have led to the development of the Good Health Research Practice (GHRP) course. Its goal is to
ensure that research is conducted to the highest possible standards, similar to the conduct of trials to GCP. The
GHRP course provides training and guidance to ensure quality and ethical conduct across all health-related
research. The GHRP course has been run so far on eight occasions. Feedback from delegates has been
overwhelmingly positive, with most delegates stating that the course was useful in developing their research
protocols and documents. Whilst most training in research starts with a guideline, GHRP has started with a
course and the experience gained over running the courses will be used to write a standardised guideline for
the conduct of health-related research outside the realm of clinical trials, so that researchers, funders and
ethics committees do not try to fit non-trials into clinical trials standards.
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Background
High-quality research is essential to achieving global
health goals; to this end, the past few years have wit-
nessed an expansion of health research activities in
low- and middle-income countries (LMICs) [1]. There
is greater demand for research institutions and scien-
tists to efficiently organise and manage research pro-
jects, as well to meet internationally recognised
standards of good practice. However, there is little
training and options available to increase research
capacities in the developing world [2, 3].
Of paramount concern to biomedical researchers are
the rights, safety and wellbeing of research partici-
pants and should be of prime importance in the plan-
ning of any health research project. In addition,
scientific integrity, including quality of the design of
the project and its ethical conduct, should play a key
role from the initial development of the project,
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through to planning, conduct and, finally, to reporting
and dissemination of the results. Thus, quality and
ethics need to be embedded into all areas of research
with human participants.
Currently available guidelines and their
limitations
Biomedical researchers have followed specific guide-
lines and regulations for many years to ensure the safe
and ethical conduct of their research; from the Nur-
emberg Code written in 1947 following the atrocities
committed by the Nazis during World War II, to the
World Medical Association’s Declaration of Helsinki
(DoH), an international ethical standard applicable to
all research on humans most recently updated in 2013
[4]. In addition to these, epidemiologists and biomed-
ical researchers use the Council for International Or-
ganizations of Medical Sciences guidelines, based on
the DoH, which focuses on ethical guidance for epi-
demiological studies and biomedical research involv-
ing humans [5, 6]. However, it lacks detailed guidance
on how to conduct scientifically sound research and
generate reliable data.
Clinical trials of investigational medicinal products
have firstly benefitted from the WHO’s Guidelines for
Good Clinical Practice (GCP) for trials on pharma-
ceutical products [7], followed by the International
Council on Harmonisation Good Clinical Practice
guidelines [8], both of which standardised the conduct
of trials across the globe. Both GCP guidelines are
international ethical and scientific quality standards
for designing, conducting, recording and reporting tri-
als involving human participants. Compliance with
GCP is expected to provide public assurance that the
rights, safety and wellbeing of participants are pro-
tected and that the clinical research data are credible.
Countries across the globe, including LMICs, now ref-
erence these as gold standard procedures for trials.
However, whilst GCP guidelines, particularly their
principles, are recommended across all research types,
it is difficult for non-clinical trial research, as is often
the case in public health with mixed qualitative and
quantitative methods, to fit in with the exacting re-
quirements of GCP.
There is therefore a need for guidelines that allow
health researchers to adhere to the principles of GCP,
which will improve the quality and ethical conduct of
all research involving human participants. These con-
cerns have led to the development of the Good Health
Research Practice (GHRP) course.
Good health research practice
Although there are limitations to applying GCP to
non-clinical trial research, the basic principles of
ethics and quality are encouraged as a means of ensur-
ing the protection of participants and validity of re-
search data. Therefore, there is a need to develop
principles and guidance similar to GCP that fit all
types of research.
WHO/TDR (the Special Programme for Research
and Training in Tropical Diseases) promotes the
integration of ethics and good research practices in
health research through short training courses. To
this end, WHO/TDR provides support for the devel-
opment of Regional Training Centres (RTCs) se-
lected among academic and research institutions in
LMICs. The goal is to establish a global network of
training centres providing a portfolio of high quality
training courses that collaborate and exchange expe-
riences in the area of good practices in health
research.
In 2010, WHO/TDR brought together scientists and
academics from these TDR-supported RTCs across the
globe to participate in the development of the GHRP
training course.
The GHRP is a training programme aimed at re-
search which falls outside the confines of clinical tri-
als. Its goal is to ensure that research is conducted to
the highest possible standards, similar to the conduct
of trials to GCP. The group used their collective ex-
perience from clinical trials and conducting other
health-related research, to develop an outline to en-
sure that all delegates would, by the end of the course,
have a fully developed protocol and associated tools
and procedures that would ensure quality of the con-
duct of the research.
The training uses a methodology based on the the-
ory of the ‘experiential learning cycle’ and follows a
‘step-by-step learning’ approach, similar to the WHO/
TDR ‘Effective project planning and evaluation’ train-
ing course. Participants apply the ethics and quality
concepts and principles to their own research project,
allowing them to learn by ‘doing’ and ‘reflecting’.
There are short theoretical sessions followed by exten-
sive practical sessions where participants work on
their concrete experience in small groups. In the plen-
ary, they share their observations for the benefit of all
participants and projects.
A key element of the course is the discussion be-
tween researchers, as it is through participatory
methods that the best possible standards for research
on human health, linking quality with ethics, can be
made. The outline of the course can be found in Box
1. The course has been designed to run over 4 days,
with a possibility of extending this based on local
requirements.
Box 1 Outline of the Good Health Research Practice
training programme (to be run over 4 days)
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Piloting and further development
The GHRP course has been run so far on eight occasions,
starting with a pilot in Heidelberg, Germany, in 2014, with
over 100 delegates attending thus far. Following each fa-
cilitation of the course, the material and exercises were re-
fined in accordance with feedback from the delegates and
trainers. Full details of the development of the course,
along with an analysis of the feedback provided by dele-
gates, have been detailed in another article [9].
Response from delegates has been overwhelmingly posi-
tive, with most delegates stating that the course was useful
in developing their research protocols and documents,
and in obtaining peer review of their study. Delegates have
so far included research project teams, Masters’ and Doc-
toral students, and have come to the course with outlines
on a variety of different projects, from qualitative, quanti-
tative and mixed methodology.
The piloting of the first few courses provided the facili-
tators with the principles of GHRP; these were developed
from the key messages that were emphasised during the
course (see Box 2 for the GHRP principles). These prin-
ciples are introduced in the first session, and are re-visited
throughout the course to ensure delegates understand
how the principles integrate within each section of the
course.
Box 2 Principles of good health research practice
The course material was finalised in December 2015
following six pilot courses, and has been translated into
Spanish and Russian. The GHRP course will expand in
the future with further translations into other languages,
including French. A train-the-trainer document was de-
veloped and completed in March 2016, and has been
piloted twice since its inception to enable building a
bank of trainers based at and around the TDR-supported
RTCs. Initially, the course is open to researchers based
at RTCs and their affiliated institutions. Gradually, RTCs
are opening the GHRP course to a broader audience as
eventually GHRP is expected to be offered more widely,
in the same way that GCP is taught around the world.
Currently, financial support for participation is provided
from TDR, but as the course gains in popularity and de-
mand, fees will likely be introduced in a similar fashion
to GCP training. GHRP is already offered as part of the
Doctoral training programme in Heidelberg, Germany,
as well as in Universitas Gadjah Mada in Yogyakarta,
Indonesia. There are plans also to submit to accreditation
schemes for international credit recognition (e.g. European
Credit Transfer and Accumulation System) to facilitate
further integration into other postgraduate training pro-
grammes. This is an instrumental part of the dissemin-
ation strategy of the course.
Conclusions
The GHRP course provides training and guidance to en-
sure quality and ethical conduct across all health-related
research. Whilst most training in research starts with a
guideline (e.g. GCP), GHRP has started with a course
1. Ethics and quality underpin all types of research involving human
participants
2. Risk assessment should be done prior to and during the course of
research with appropriate mitigation measures put in place
3. Informed consent should be appropriate for the study and in
accordance with the cultural context of the study site
4. Procedures should be written in line with the study protocol to
ensure consistency and conformance of activities
5. Staff qualified through appropriate training, education and
experience will undertake roles in line with their qualification
6. Study activities should be well planned and monitored to assure the
process and data quality
7. Privacy of the research participants and confidentiality of all data
acquired during the study should be duly protected
8. Research results and reports should be made publicly available
Module 1: Introduction
Session 1: Course introduction and overview
Session 2: Principles of research ethics and quality
Exercise 1: Risk assessment
Module 2: Designing and planning the research
Session 2.1: Study planning and management
Session 2.2.1: Developing the research protocol
Exercise 2: Gap analysis of protocol
Session 2.2.2: Informed consent form
Exercise 3: Review of informed consent form
Session 2.2.3: Tools for collecting data
Exercise 4: List data to be collected and draft data collection strategy
Session 2.2.4: Tools for study conduct and essential documents
Exercise 5: Identify and list key critical procedures and tools
Session 2.3: Stakeholders, study team and study sites
Exercise 6: Objectives, key steps/deliverables, work breakdown structure
Exercise 7: Organisational breakdown structure and study site checklists
Session 2.4: Research oversight
Module 3: Conducting, recording and monitoring the research
Session 3.1: Informed consent procedure
Exercise 8: Role-play
Session 3.2: Managing and analysing data
Session 3.3: Quality system
Module 4: Evaluating and reporting the research
Session 4.1: Evaluating research projects
Session 4.2: Reporting and disseminating research results
Exercise 9: Dissemination plan
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and the experience gained over running the courses will
be used to write a standardised guideline for the conduct
of health-related research outside the realm of clinical
trials, so that researchers, funders and ethics committees
do not try to fit non-trials into clinical trial standards.
By widely disseminating the course, it is expected to
generate sufficient experience and evidence that would
inform the development of new pragmatic guidelines
applicable to all types of human research; thus, it is
hoped that GHRP becomes as ubiquitous as GCP due
to its wide applicability and positive feedback received
thus far.
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